Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.
Abdelmalak J, Strasser SI, Ngu NL, Dennis C, Sinclair M, Majumdar A, Collins K, Bateman K, Dev A, Abasszade JH, Valaydon Z, Saitta D, Gazelakis K, Byers S, Holmes J, Thompson AJ, Howell J, Pandiaraja D, Bollipo S, Sharma S, Joseph M, Sawhney R, Nicoll A, Batt N, Tang MJ, Riordan S, Hannah N, Haridy J, Sood S, Lam E, Greenhill E, Lubel J, Kemp W, Majeed A, Zalcberg J, Roberts SK. Abdelmalak J, et al. Among authors: batt n. Cancers (Basel). 2024 Aug 29;16(17):3010. doi: 10.3390/cancers16173010. Cancers (Basel). 2024. PMID: 39272868 Free PMC article.
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study.
Abdelmalak J, Strasser SI, Ngu N, Dennis C, Sinclair M, Majumdar A, Collins K, Bateman K, Dev A, Abasszade JH, Valaydon Z, Saitta D, Gazelakis K, Byers S, Holmes J, Thompson AJ, Pandiaraja D, Bollipo S, Sharma S, Joseph M, Nicoll A, Batt N, Sawhney R, Tang MJ, Lubel J, Riordan S, Hannah N, Haridy J, Sood S, Lam E, Greenhill E, Majeed A, Kemp W, Zalcberg J, Roberts SK. Abdelmalak J, et al. Among authors: batt n. Cancers (Basel). 2023 Dec 7;15(24):5741. doi: 10.3390/cancers15245741. Cancers (Basel). 2023. PMID: 38136287 Free PMC article.
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study.
Abdelmalak J, Strasser SI, Ngu NL, Dennis C, Sinclair M, Majumdar A, Collins K, Bateman K, Dev A, Abasszade JH, Valaydon Z, Saitta D, Gazelakis K, Byers S, Holmes J, Thompson AJ, Pandiaraja D, Bollipo S, Sharma S, Joseph M, Sawhney R, Nicoll A, Batt N, Tang MJ, Riordan S, Hannah N, Haridy J, Sood S, Lam E, Greenhill E, Lubel J, Kemp W, Majeed A, Zalcberg J, Roberts SK. Abdelmalak J, et al. Among authors: batt n. Cancers (Basel). 2024 May 22;16(11):1966. doi: 10.3390/cancers16111966. Cancers (Basel). 2024. PMID: 38893086 Free PMC article.
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy.
Batt NM, Rodrigues B, Bloom S, Sawhney R, George ES, Hodge A, Vootukuru N, McCrae C, Sood S, Roberts SK, Dev A, Bell S, Thompson A, Ryan MC, Kemp W, Gow PJ, Sood S, Nicoll AJ. Batt NM, et al. J Gastroenterol Hepatol. 2024 Jun;39(6):1048-1056. doi: 10.1111/jgh.16501. Epub 2024 Feb 18. J Gastroenterol Hepatol. 2024. PMID: 38369382
Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia.
Nash E, Nicoll A, Batt N, George J, Perananthan V, Prince D, Wallace M, Gow P, Vaz K, Chitturi S, Flores JE, Braund A, Bonnichsen M, Riordan S, Humphris J, Duong T, McKenzie C, Liu K, Strasser SI. Nash E, et al. Among authors: batt n. Aliment Pharmacol Ther. 2024 Apr;59(8):953-961. doi: 10.1111/apt.17906. Epub 2024 Feb 19. Aliment Pharmacol Ther. 2024. PMID: 38372012
The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease.
Bohra A, Batt N, Dutt K, Lewis D, Segal JP, Newiadomski O, Vasudevan A, Langenberg DRV. Bohra A, et al. Among authors: batt n. Therap Adv Gastroenterol. 2024 Mar 13;17:17562848241237895. doi: 10.1177/17562848241237895. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38486818 Free PMC article.
14 results